Samrat Pharma
Company Overview - January 14, 2025
Samrat Pharma is a notable player in the Pharmaceuticals - Indian - Bulk Drugs industry, listed on the BSE (Code: 530125). As of the January 14, 2025, the company holds a market capitalization of INR 131.61 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 425.90, Samrat Pharma has demonstrated a 21.78% return over the last year. Recent performance indicates fluctuations, with a 0.31% change in the past week and a -4.31% change over the last month. The company's all-time high stands at INR 1250.00, while its lowest-ever price was INR 6.21.
In terms of sales, Samrat Pharma reported a revenue of INR 295.34 crores, solidifying its position in the market. The average trading volume over the past month has been 2720 shares, with a more recent weekly average of 2992.
With the stock trading below its 50-day moving average of INR 477.09, the company's technical indicators like MACD (-14.95) signal negative trends.
Company Data
| Name | Samrat Pharma |
|---|---|
| BSE Code | 530125 |
| NSE Code | |
| Industry | Pharmaceuticals - Indian - Bulk Drugs |
| Current Price | 425.90 |
| Market Capitalization | 131.61 |
| Sales | 295.34 |
| Return over 3months | 1.32 |
| Return over 6months | 24.43 |
| Volume 1month average | 2720 |
| Volume 1week average | 2992 |
| Volume | 5360 |
| High price | 646.00 |
| Low price | 320.00 |
| High price all time | 1250.00 |
| Low price all time | 6.21 |
| Return over 1day | -3.71 |
| Return over 1week | 0.31 |
| Return over 1month | -4.31 |
| Return over 1year | 21.78 |
| Return over 3years | 24.24 |
| Return over 5years | 36.58 |
| Volume 1year average | 7123 |
| DMA 50 | 477.09 |
| DMA 200 | 435.95 |
| DMA 50 previous day | 478.51 |
| DMA 200 previous day | 435.88 |
| MACD | -14.95 |
| MACD Signal | -13.85 |